Barijak, containing the active ingredient Baricitinib, is a medication primarily used for the treatment of moderate to severe rheumatoid arthritis in adults. It works by inhibiting specific enzymes to reduce inflammation and pain associated with this condition.
Barijak is indicated for:
Baricitinib is a Janus kinase (JAK) inhibitor, which helps to block the activity of enzymes involved in the inflammatory process. This action reduces the symptoms of arthritis, such as swelling, pain, and stiffness.
The recommended dosage for adults is one 4mg tablet taken once daily. It is essential to follow your healthcare provider's instructions regarding dosage adjustments and duration of therapy.
Common side effects may include:
Serious side effects can occur, including infections, blood clots, and gastrointestinal perforations. Contact your healthcare provider immediately if you experience any severe symptoms.
Before taking Barijak, inform your healthcare provider about any other medications you are taking, as well as any existing health conditions. Regular monitoring of blood counts and liver function tests is recommended during treatment.
Barijak 4mg is an effective option for managing moderate to severe rheumatoid arthritis and may provide relief from debilitating symptoms. Always consult with a healthcare professional to determine if this medication is right for you.